Provided by Tiger Trade Technology Pte. Ltd.

GeoVax Labs Inc

0.1848
-0.0188-9.23%
Pre-market: 0.1700-0.0148-8.01%04:19 EST
Volume:3.24M
Turnover:615.89K
Market Cap:8.00M
PE:-0.11
High:0.1950
Open:0.1900
Low:0.1835
Close:0.2036
52wk High:2.32
52wk Low:0.1151
Shares:43.30M
Float Shares:29.97M
Volume Ratio:1.02
T/O Rate:10.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6295
EPS(LYR):-4.8182
ROE:-377.44%
ROA:-178.93%
PB:1.63
PE(LYR):-0.04

Loading ...

BRIEF-Gordian Bio Announces Research Collaboration With Pfizer

Reuters
·
Yesterday

GeoVax Labs: Files for Prospectus Relates to Public Offering of 18.3 Mln Units - SEC Filing

THOMSON REUTERS
·
Dec 13, 2025

GeoVax Labs Inc. held special shareholder meeting

Reuters
·
Nov 27, 2025

Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX) and 4D Molecular Therapeutics (FDMT)

TIPRANKS
·
Nov 18, 2025

GeoVax Labs reports third quarter net loss and lower revenue

Reuters
·
Nov 14, 2025

Geovax Labs Q3 EPS $(0.31) Misses $(0.25) Estimate

Benzinga
·
Nov 14, 2025

GeoVax Labs Inc expected to post a loss of 26 cents a share - Earnings Preview

Reuters
·
Nov 08, 2025

GeoVax Labs (GOVX) Receives a Buy from Roth MKM

TIPRANKS
·
Oct 24, 2025

GeoVax Labs Director John N. Spencer Jr. Acquires Common Shares

Reuters
·
Oct 20, 2025

GeoVax Labs files to sell 11.9M shares of common stock for holders

TIPRANKS
·
Oct 18, 2025

GeoVax Labs Inc. Announces Date for Special Stockholders Meeting

Reuters
·
Oct 04, 2025

GeoVax Labs Inc: Announces $2.5 Mln Registered Direct Offering

THOMSON REUTERS
·
Oct 01, 2025

GeoVax Labs Announces $2.5 Million Registered Direct Offering of Common Stock and Warrants to Institutional Investors

Reuters
·
Oct 01, 2025

GeoVax Labs Inc. Chief Medical Officer, Kelly T. McKee Jr., Reports Acquisition of Common Shares

Reuters
·
Aug 09, 2025

GeoVax Labs Inc. Faces Potential Nasdaq Delisting Due to Non-Compliance with $1.00 Minimum Bid Price Requirement

Reuters
·
Aug 02, 2025

BRIEF-Geovax Labs To Initiate Phase 3 Trial In second half of 2026

Reuters
·
Jul 29, 2025

GeoVax Labs Inc - to Initiate Phase 3 Trial in 2H 2026 - SEC Filing

THOMSON REUTERS
·
Jul 29, 2025

Geovax Labs Q2 EPS $(0.35) Beats $(0.36) Estimate, Sales $852.282K Beat $366.667K Estimate

Benzinga
·
Jul 29, 2025